| Literature DB >> 29329299 |
Adam Akullian1,2, Joel M Montgomery2,3, Grace John-Stewart2, Samuel I Miller4, Hillary S Hayden4, Matthew C Radey4, Kyle R Hager4, Jennifer R Verani2,3, John Benjamin Ochieng5, Jane Juma5, Jim Katieno5, Barry Fields6, Godfrey Bigogo5, Allan Audi5, Judd Walson2,7.
Abstract
Non-typhoidal Salmonella (NTS) is a leading cause of bloodstream infections in Africa, but the various contributions of host susceptibility versus unique pathogen virulence factors are unclear. We used data from a population-based surveillance platform (population ~25,000) between 2007-2014 and NTS genome-sequencing to compare host and pathogen-specific factors between individuals presenting with NTS bacteremia and those presenting with NTS diarrhea. Salmonella Typhimurium ST313 and Salmonella Enteritidis ST11 were the most common isolates. Multi-drug resistant strains of NTS were more commonly isolated from patients presenting with NTS bacteremia compared to NTS diarrhea. This relationship was observed in patients under age five [aOR = 15.16, 95% CI (2.84-81.05), P = 0.001], in patients five years and older, [aOR = 6.70 95% CI (2.25-19.89), P = 0.001], in HIV-uninfected patients, [aOR = 21.61, 95% CI (2.53-185.0), P = 0.005], and in patients infected with Salmonella serogroup B [aOR = 5.96, 95% CI (2.28-15.56), P < 0.001] and serogroup D [aOR = 14.15, 95% CI (1.10-182.7), P = 0.042]. Thus, multi-drug-resistant NTS was strongly associated with bacteremia compared to diarrhea among children and adults. This association was seen in HIV-uninfected individuals infected with either S. Typhimurium or S. Enteritidis. Risk of developing bacteremia from NTS infection may be driven by virulence properties of the Salmonella pathogen.Entities:
Mesh:
Substances:
Year: 2018 PMID: 29329299 PMCID: PMC5785031 DOI: 10.1371/journal.pntd.0006156
Source DB: PubMed Journal: PLoS Negl Trop Dis ISSN: 1935-2727
Fig 1Sample flow chart for inclusion of NTS clinical isolates.
Prevalence of host- and pathogen- characteristics by NTS clinical outcome (bacteremia versus diarrhea), stratified on age under and over 5 years.
| Age < 5 years | Age ≥5 years | |||||
|---|---|---|---|---|---|---|
| NTS diarrhea | NTS bacteremia | P—value | NTS diarrhea | NTS bacteremia | P—value | |
| n = 16 | n = 117 | n = 57 | n = 113 | |||
| n (%) / | n (%) / | n (%) / | n (%) / | |||
| Age (mean (sd)) | 1.32 (0.90) | 2.22 (1.14) | 32.46 (20.19) | 26.87 (18.13) | 0.070 | |
| Sex (% female) | 5 (31.2) | 57 (48.7) | 0.285 | 30 (52.6) | 68 (60.2) | 0.438 |
| Nutritional status at presentation | ||||||
| Wasted (WHZ < -2.0) | 3 (21.4) | 16 (14.8) | 0.456 | NA | NA | NA |
| Stunted (HAZ < -2.0) | 6 (40.0) | 33 (29.7) | 0.610 | NA | NA | NA |
| Severe acute | 1 (7.1) | 7 (6.5) | 1.000 | NA | NA | NA |
| Any medication taken for illness prior to presentation | 7 (43.8) | 64 (54.7) | 0.578 | 29 (50.9) | 52 (46.0) | 0.663 |
| TMP/SMX taken | 1 (6.2) | 9 (8.0) | 1.000 | 2 (3.8) | 3 (2.9) | 1.000 |
| Other antibiotic taken | 0 (0.0) | 2 (1.8) | 1.000 | 5 (9.6) | 2 (1.9) | |
| Received HIV test | 1 (6.3) | 13 (11.1) | 0.552 | 27 (47.4) | 46 (40.7) | 0.408 |
| HIV positive | 0 (0.0) | 6 (46.2) | 1.000 | 11 (40.7) | 33 (71.7) | |
| HIV positive (status confirmed at NTS dx) | 0 (0.0) | 6 (46.2) | 1.000 | 1 (16.7) | 19 (79.2) | |
| Malaria smear positive | 3 (21.4) | 33 (29.2) | 0.756 | 3 (7.3) | 19 (19.6) | 0.080 |
| Serogroup | ||||||
| Group B | 7 (43.8) | 75 (64.1) | 28 (49.1) | 77 (68.8) | ||
| Group C1/C2 | 4 (25.0) | 0 (0.0) | 13 (22.8) | 0 (0.0) | ||
| Group D | 3 (18.8) | 40 (34.2) | 11 (19.3) | 35 (31.2) | ||
| Undefined | 2 (12.5) | 2 (1.7) | 5 (8.8) | 0 (0.0) | ||
| 0.346 | ||||||
| Typhimurium ST313 | 0 (0.0) | 49 (57.6) | 6 (35.3) | 54 (66.7) | ||
| Typhimurium ST19 | 0 (0.0) | 2 (2.4) | 0 (0.0) | 1 (1.2) | ||
| Enteritidis ST11 | 1 (33.3) | 33 (38.8) | 5 (29.4) | 24 (29.6) | ||
| Enteritidis ST6 | 0 (0.0) | 0 (0.0) | 0 (0.0) | 1 (1.2) | ||
| Virchow ST16 | 2 (66.7) | 1 (1.2) | 1 (5.9) | 0 (0.0) | ||
| Heidelberg ST15 | 0 (0.0) | 0 (0.0) | 1 (5.9) | 0 (0.0) | ||
| Newport ST188 | 0 (0.0) | 0 (0.0) | 0 (0.0) | 1 (1.2) | ||
| Unknown ST1162 | 0 (0.0) | 0 (0.0) | 1 (5.9) | 0 (0.0) | ||
| Unknown ST1817 | 0 (0.0) | 0 (0.0) | 2 (11.8) | 0 (0.0) | ||
| Drug resistance | ||||||
| TMP-SMX | 5 (35.7) | 98 (89.9) | 18 (34.0) | 96 (91.4) | ||
| Ampicillin | 4 (28.6) | 96 (88.9) | 20 (37.7) | 94 (90.4) | ||
| Chloramphenicol | 3 (21.4) | 91 (84.3) | 15 (28.3) | 83 (79.0) | ||
| Multi-drug resistant | 3 (21.4) | 90 (83.3) | 14 (26.4) | 81 (77.1) |
Numbers and percentages out of all non-missing records
1 P-value test for difference in the proportions / means of co-factors between NTS bacteremia and NTS diarrhea by age group, calculated using a chi-squared statistic for differences in proportions and T-test for differences in mean values. Fisher’s exact test used to test difference in proportions with cell values of 5 or less.
2 Among those with non-missing responses to having taken any medication for the current illness
3 HIV status ascertained through two community surveillance surveys conducted in 2008–2009 and 2013.
4Among those presenting with fever or history of fever
5Serogroup identified by commercial agglutinating antiserum
6Based on Multi-Locus Sequence Typing (MLST). Among 3 NTS diarrhea and 85 NTS bacteremia specimens genotyped from patients under age five; and among 16 NTS diarrhea and 81 NTS bacteremia specimens genotyped from patients age five and older.
7Resistance to TMP-SMX, Ampicillin, and Chloramphenicol
Fig 2Maximum likelihood phylogeny of 115 S. Typhimurium strains (3 strains are from the same patient at separate visits within one month and are not included in the epidemiologic analysis) based on k-mers.
Each strain is represented by collection year for clarity (strain numbers can be found in the S1 Table). NTS bacteremic and diarrheal clinical strains are colored blue and red, respectively. Reference strains appear in black text. Bold text indicates strains collected from patients under 5 years of age. Filled and open squares indicate HIV positive and negative hosts, respectively, when known. Clinical strains susceptible to TMP-SMX, ampicillin (AMP) and/or chloramphenicol (CHL) are indicated with filled circles. Strains with unknown susceptibilities are indicated with an asterisk (*). Basal branches with 100% local support are labeled. The tree was rooted with laboratory strain 14028S.
Association between host- and pathogen- characteristics and NTS clinical outcome (bacteremia vs. diarrhea), stratified on age under/over five years.
Multivariate- adjusted odds ratios,indicate the odds of bacteremia divided by the odds of diarrhea by co-variate, adjusted for other co-variates. Note estimates not adjusted for HIV due to small sample size. See Table 3 for HIV-stratified results.
| Age < 5 years (N = 114) | Age ≥ 5 years (N = 116) | |||||
|---|---|---|---|---|---|---|
| aOR | 95% CI | P-value | aOR | 95% CI | P-value | |
| Age (years) | 2.17 | (0.48–9.84) | 0.314 | 1.00 | (0.97–1.03) | 0.985 |
| Year of diagnosis | 1.39 | (0.80–2.41) | 0.245 | 1.24 | (0.88–1.74) | 0.226 |
| Malaria (smear positive) | 1.86 | (0.23–14.72) | 0.559 | 4.02 | (0.43–37.28) | 0.221 |
| Serogroup | ||||||
| Group B | 1.97 | (0.41–9.42) | 0.394 | 0.44 | (0.12–1.55) | 0.202 |
| | 0.93 | (0.05–17.14) | 0.960 | NA | - | - |
| Group D | 1.00 | ref | - | 1.00 | ref | - |
| Multi-drug resistant (MDR) | 15.16 | (2.84–81.05) | 6.70 | (2.25–19.89) | ||
All cases of NTS serogroup C1/C2 were dropped from the multivariate model (N = 2 for age < 5 and N = 8) as they were only found in diarrhea patients and thus predicted NTS bacteremia versus diarrhea perfectly. Similarly, all cases of Salmonella spp. in individuals age five and older were dropped (N = 4) as they predicted NTS bacteremia versus diarrhea perfectly.
Multivariate-adjusted odds ratios stratified on HIV status.
| Strata | HIV negative (n = 31) | HIV positive (n = 43) | ||||
|---|---|---|---|---|---|---|
| aOR | 95% CI | P-value | aOR | 95% CI | P-value | |
| Age (years) | 1.00 | (0.94–1.07) | 0.942 | 1.00 | (0.96–1.05) | 0.950 |
| Year of diagnosis | 1.16 | (0.47–2.90) | 0.743 | 1.17 | (0.42–3.24) | 0.766 |
| Serogroup | ||||||
| Group B | 0.55 | (0.05–5.44) | 0.607 | 0.61 | (0.05–7.33) | 0.697 |
| Group D | 1.00 | Ref | - | 1.00 | Ref | - |
| Multi-drug resistant (MDR) | 21.61 | (2.53–184.99) | 2.74 | (0.48–15.66) | 0.258 | |
Concurrent malaria parasitemia was not found in any NTS diarrheal patients and was only found in one NTS bacteremia case and was therefore removed as a co-factor from the model